peripheral nervous system disease: A disease involving the peripheral nervous system.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
66 |
4. Check minimum number of eventsNone |
66 |
5. Include endpointsNone |
66 |
6. Filter based on genotype QC (FinnGen only) |
66 |
Control definitions (FinnGen only)
- Control exclude
- G6_NERPLEX
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G54
- Name in latin
- Morbositates radicum nervorum thoracicorum non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Thoracic root disorders
based on the number of shared cases.
Similar with more cases:
- Nerve, nerve root and plexus disorders
- Neurological diseases
- Neurological diseases, wide definition
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 501 | 279 | 218 |
| Only index persons | 448 | 254 | 194 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 52.51 | 54.30 | 50.10 |
| Only index persons | 51.22 | 52.91 | 49.02 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 66 | 39 | 27 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 51.00 | 49.17 | 53.64 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 60
- Matched controls
- 599
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G54.3
ICD-10 Finland
Thoracic root disorders, not elsewhere classified
+∞
74.2
55
*
N03AX16
ATC
pregabalin; oral
7.1
10.3
30
74
N03AX12
ATC
gabapentin; oral
6.8
8.4
23
50
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
29.4
7.9
10
*
G54.0
ICD-10 Finland
Brachial plexus disorders
90.9
7.6
8
*
N06AA09
ATC
amitriptyline; systemic
8.0
7.5
17
28
R60.0
ICD-10 Finland
Localized oedema
8.7
7.1
15
22
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
19.6
7.0
10
6
N02AX02
ATC
tramadol; systemic, rectal
4.4
6.8
39
178
N06AX21
ATC
duloxetine; oral
6.3
6.6
18
38
M54.5
ICD-10 Finland
Low back pain
4.2
6.3
31
122
M54.9
ICD-10 Finland
Dorsalgia, unspecified
6.6
6.3
16
31
G56.0
ICD-10 Finland
Carpal tunnel syndrome
17.3
6.1
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
37
184
3.30
5.38
2.3
2.0
pmol/l
92.7
95.7
0.16
26
96
(42870588) Differential panel, method unspecified - Blood
31
152
2.96
4.43
5.3
5.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
17
60
3.47
4.17
1.8
2.3
g/l
2.4
2.4
0.03
17
53
(3022948) Iron [Moles/volume] in Serum or Plasma
18
66
3.38
4.16
1.9
2.3
umol/l
10.0
14.7
1.50
18
59
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
19
75
3.15
3.89
3.2
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
53
3.37
3.64
3.5
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
38
226
2.61
3.54
6.3
5.3
%
0.7
0.6
0.24
38
215
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
15
54
3.30
3.53
3.7
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
39
235
2.61
3.53
6.2
5.4
%
58.7
58.0
0.16
39
226
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
42
263
2.64
3.50
8.2
6.2
umol/l
9.9
10.2
0.13
42
243
(3002030) Lymphocytes/100 leukocytes in Blood
39
236
2.60
3.49
6.5
5.5
%
25.5
27.2
0.39
39
226
(3032080) INR in Blood by Coagulation assay
33
185
2.57
3.45
9.1
8.8
inr
1.1
1.2
0.43
12
53
(3006504) Eosinophils/100 leukocytes in Blood
38
231
2.52
3.31
6.2
5.5
%
2.6
2.6
0.00
38
221
(3019069) Monocytes/100 leukocytes in Blood
38
232
2.50
3.27
6.5
5.7
%
9.1
8.4
0.78
38
224
(3012544) pH of Venous blood
11
36
3.47
2.96
3.4
3.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
51
367
2.71
2.96
5.4
3.7
mm/h
14.9
11.9
0.52
51
337
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
13
5.88
2.95
1.7
2.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
46
322
2.41
2.73
4.6
4.6
—
1424.3
—
0
8
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
36
228
2.27
2.69
6.7
4.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
11
40
3.10
2.51
2.5
4.0
g/l
8.7
10.6
1.26
11
35
(3023368) Bacteria identified in Blood by Culture
22
116
2.34
2.49
5.0
4.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
29
3.43
2.33
14.9
5.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
14
62
2.60
2.26
1.2
1.4
—
373.3
—
0
12
(3007164) IgA [Mass/volume] in Serum or Plasma
18
91
2.34
2.22
1.4
1.6
g/l
2.6
3.2
0.48
13
62
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
21
115
2.21
2.15
3.4
1.8
mg/l
2.8
3.2
0.73
21
100
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
5
10
5.31
2.11
2.2
2.5
ug/l
365.4
248.3
—
5
10
(3044889) 12 lead EKG panel
49
374
2.20
2.07
4.6
3.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
22
3.43
1.94
19.4
11.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
28
3.11
1.93
1.3
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
21
120
2.10
1.91
3.1
2.8
mg/l
2629.5
73.1
0.47
16
73
(3028026) IgM [Mass/volume] in Serum or Plasma
9
35
2.81
1.88
1.3
1.7
g/l
1.2
1.1
—
9
29
(3012095) Magnesium [Moles/volume] in Serum or Plasma
15
75
2.29
1.88
5.1
2.7
mmol/l
0.8
0.8
0.09
15
69
(3030467) Casts [#/volume] in Urine by Automated count
21
121
2.08
1.87
2.8
2.6
e6/l
1.7
0.2
0.48
15
94
(36304419) Bacteria [Presence] in Urine
21
121
2.08
1.87
2.2
2.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
35
243
1.94
1.85
3.8
3.7
estimate
0.0
0.0
—
6
53
(3037467) Urinalysis macro (dipstick) panel - Urine
44
334
1.95
1.74
5.3
4.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
35
247
1.89
1.72
3.8
3.8
estimate
0.0
0.0
—
6
52
(3044640) Blood type and Crossmatch panel - Blood
24
151
1.93
1.66
2.5
2.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
26
2.89
1.63
2.6
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
34
241
1.85
1.63
4.8
4.8
estimate
0.0
0.0
—
6
54
(40761535) Cells panel - Urine sediment
8
33
2.62
1.60
5.4
3.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
21
130
1.90
1.51
4.5
3.7
mg/mmol
4.4
11.1
0.96
16
74
(40768443) Skin Pathology biopsy report
6
23
2.76
1.40
1.3
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
23
2.76
1.40
1.7
3.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
23
150
1.82
1.40
2.3
3.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
17
3.09
1.38
1.0
3.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
17
101
1.92
1.36
3.7
3.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
24
2.64
1.33
1.2
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
24
161
1.77
1.32
2.8
3.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
20
127
1.82
1.31
9.9
7.0
—
—
—
0
0
(3015736) pH of Urine
27
188
1.74
1.31
3.3
3.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
5
18
2.92
1.31
4.0
13.3
mmol/l
25.0
24.6
—
5
18
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
12
66
2.00
1.18
2.0
2.6
e6/l
0.3
3.3
—
7
42
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
5
20
2.62
1.17
2.8
2.4
%
0.7
0.8
—
5
20
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
59
527
2.13
1.15
25.3
13.2
mg/l
25.6
23.5
0.13
53
405
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
12
67
1.97
1.13
2.0
2.5
e6/l
1.2
1.0
—
7
43
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
21
2.49
1.11
2.8
2.5
%
2.5
1.0
—
5
21
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
14
84
1.85
1.08
1.4
1.2
u/ml
10.7
3.4
—
6
29
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
14
86
1.80
1.01
1.5
1.2
iu/ml
15.7
23.3
—
7
24
(40768797) Stomach Pathology biopsy report
12
70
1.87
1.00
1.0
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
28
209
1.59
1.00
4.7
2.4
ug/l
100.1
115.3
0.29
28
191
(3002582) Erythrocytes [#/volume] in Urine
20
137
1.66
0.99
2.9
2.9
e6/l
25.1
39.5
0.32
14
111
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
51
1.88
0.99
1.4
2.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
55
1.96
0.98
1.3
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
30
2.10
0.89
5.2
8.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
46
1.84
0.86
1.3
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
16
108
1.64
0.83
3.0
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
11
67
1.77
0.81
1.8
1.5
%
1.4
1.3
0.25
11
55
(3022313) Gas panel - Capillary blood
0
24
0.00
0.81
0.0
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
27
208
1.50
0.81
2.0
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
59
541
1.85
0.77
28.9
14.9
mmol/l
4.0
4.0
0.19
59
529
(40760892) CBC W Ordered Manual Differential panel - Blood
18
128
1.56
0.76
4.8
4.0
—
—
—
0
0
(4034850)
5
24
2.17
0.76
15.6
9.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
21
155
1.52
0.76
3.0
3.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
25
2.08
0.74
1.2
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
22
166
1.49
0.71
3.7
3.2
e6/l
33.3
37.5
0.07
16
125
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
27
1.92
0.70
1.2
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
26
205
1.44
0.67
4.0
3.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
11
71
1.66
0.67
6.7
2.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
8
49
1.72
0.65
2.6
4.6
%
2.2
2.1
—
8
44
(3025941) Bacteria identified in Stool by Culture
5
29
1.78
0.65
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
19
142
1.47
0.64
4.6
4.1
estimate
0.0
0.0
—
6
51
(3004588) Protein electrophoresis panel - Serum or Plasma
5
30
1.72
0.62
1.0
3.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
58
537
1.66
0.62
29.2
14.9
mmol/l
139.8
139.7
0.23
58
525
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
19
0.00
0.61
0.0
1.8
—
24.2
—
0
19
(3022621) pH of Urine by Test strip
6
35
1.78
0.59
1.3
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
9
59
1.61
0.58
4.1
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
59
1.61
0.58
1.7
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
18
138
1.42
0.53
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
17
217
0.71
0.53
3.2
2.7
—
—
—
0
0
(4010399)
5
32
1.61
0.43
1.4
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
11
81
1.43
0.39
1.6
1.6
—
—
—
0
0
(4035726)
6
41
1.51
0.37
1.0
1.3
—
—
—
0
0
(3013512) EKG study
17
138
1.31
0.35
3.7
3.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
24
205
1.27
0.34
3.7
3.7
ng/l
43.7
41.5
0.03
19
121
(3020564) Creatinine [Moles/volume] in Serum or Plasma
59
562
1.47
0.33
28.1
14.7
umol/l
76.2
77.8
0.20
59
562
(40761511) CBC panel - Blood by Automated count
58
555
1.37
0.32
27.3
12.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
91
0.74
0.24
1.9
2.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
59
569
1.35
0.24
14.6
9.4
u/l
26.1
25.6
0.07
59
555
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
37
343
1.18
0.21
2.7
3.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
13
0.00
0.21
0.0
2.1
—
110.1
—
0
8
(4094501)
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
1.8
—
0
5
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
51
489
1.19
0.17
15.4
12.4
ml/min/173m2
81.9
80.9
0.10
44
399
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
5
44
1.15
0.10
1.6
2.1
ug/l
3.8
6.5
—
5
37
(40761536) Microorganisms panel - Urine sediment
5
45
1.12
0.10
6.2
3.9
—
—
—
0
0
(3002256) Pathology report gross observation
6
54
1.12
0.09
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
74
1.09
0.08
1.0
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
80
0.86
0.07
2.1
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
49
481
1.07
0.03
28.4
14.1
%
39.9
40.0
0.02
33
381
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
14
145
0.96
0.00
4.0
4.5
ug/l
1.3
4.4
0.85
14
139
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
27.4
—
0
5
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3000492) Spirometry study
5
55
0.90
0.00
1.2
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
59
589
1.02
0.00
38.1
19.0
e9/l
260.5
247.5
0.85
59
579
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
52
0.96
0.00
4.0
3.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
5
56
0.88
0.00
2.2
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
59
589
1.02
0.00
37.8
19.0
pg
30.2
30.3
0.21
59
584
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
0.3
—
0
6
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
14.7
—
0
6
(3022806) Fractional oxyhemoglobin in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
89.8
—
0
6
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
5.2
—
40.6
—
0
6
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
6
0.00
0.00
0.0
1.0
—
32.8
—
0
6
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
5
54
0.92
0.00
3.0
1.5
nmol/l
568.8
403.2
—
5
49
(3028271) Lactate [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.7
—
1.2
—
0
7
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
59
590
1.00
0.00
37.9
18.9
fl
91.3
91.1
0.15
59
585
(3023410) Appearance of Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
59
0.84
0.00
1.2
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
59
591
0.98
0.00
38.2
19.1
g/l
132.3
135.5
0.75
59
586
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_THROOT and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have G6_THROOT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: G6_THROOT – Thoracic root disorders
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data